BLRX

BioLineRX

19 hedge funds and large institutions have $6.66M invested in BioLineRX in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
BI
1
BVF Inc
California
$2.77M 1,686,375
Morgan Stanley
2
Morgan Stanley
New York
$1.26M 768,335 +203,221 +36%
KCM
3
Kennedy Capital Management
Missouri
$1.14M 695,552 +695,552 New
SM
4
Senvest Management
New York
$543K 331,205 -120,000 -27%
Renaissance Technologies
5
Renaissance Technologies
New York
$438K 267,274 +109,924 +70%
PVH
6
Psagot Value Holdings
Israel
$192K 117,000
O
7
OrbiMed
New York
$114K 69,240
CCB
8
Cutter & Co Brokerage
Missouri
$48K 29,000 +11,201 +63%
Goldman Sachs
9
Goldman Sachs
New York
$39K 23,916 -13,957 -37%
OM
10
Opaleye Management
Massachusetts
$33K 16,667
LPL Financial
11
LPL Financial
California
$28K 16,876 -3,000 -15%
Creative Planning
12
Creative Planning
Kansas
$22K 13,582 +2,000 +17%
TNB
13
Thomasville National Bank
Georgia
$21K 12,500 +12,500 New
UBS Group
14
UBS Group
Switzerland
$7K 4,174 +4,174 New
NFG
15
Next Financial Group
Texas
$6K 3,598 +3,598 New
RE
16
RBC Europe
United Kingdom
$21 13
Acadian Asset Management
17
Acadian Asset Management
Massachusetts
-18,973 Closed
ADL
18
Asset Dedication LLC
California
-366 Closed
CFGS
19
Concourse Financial Group Securities
Alabama
Wells Fargo
20
Wells Fargo
California
$0 35
IA
21
IFP Advisors
Florida
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$0 199
Osaic Holdings
23
Osaic Holdings
Arizona
$0 139